These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 406557)

  • 21. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
    Prival MJ; Mitchell VD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic activation capabilities of S9 liver fraction from 3 species in the L5178Y mouse-lymphoma assay.
    Oberly TJ; Piper CE; McDonald DS
    Mutat Res; 1982 Dec; 105(6):439-44. PubMed ID: 6818472
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of glutathione and uridine 5'-diphosphoglucuronic acid on benzo(a)pyrene mutagenesis in the Salmonella/microsome assay.
    Malaveille C; Brun G; Hautefeuille A; Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():175-80. PubMed ID: 6273102
    [No Abstract]   [Full Text] [Related]  

  • 24. The importance of 2-aminofluorene in the mutagenic activation of 2-acetylaminofluorene.
    Robertson IG
    Mutat Res; 1986 Nov; 175(3):153-7. PubMed ID: 3534560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of metabolic activation for four mutagens in a bacterial, fungal and two mammalian cell mutagenesis assays.
    Rees RW; Brice AJ; Carlton JB; Gilbert PJ; Mitchell ID
    Mutagenesis; 1989 Sep; 4(5):335-42. PubMed ID: 2687626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimum S9 concentrations in bacterial mutagenicity assays.
    Forster R; Green MH; Priestley A
    Adv Exp Med Biol; 1981; 136 Pt B():1263-9. PubMed ID: 7046386
    [No Abstract]   [Full Text] [Related]  

  • 27. Activation of liver microsomes by 2,3,4,5-tetrachlorophenol.
    Süssmuth R; Ackermann-Schmidt B; Lingens F
    Mutat Res; 1980 Mar; 77(3):279-82. PubMed ID: 6991923
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanisms of butylated hydroxytoluene-mediated modulation of 2-acetylaminofluorene mutagenicity in rat and human hepatocyte/Salmonella assays.
    Chipman JK; Davies JE; Paterson P
    Mutat Res; 1987 Mar; 187(3):105-12. PubMed ID: 3547109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
    Gatehouse D; Wedd DJ
    Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of mutagens in cooked ground beef by human-liver microsomes.
    Felton JS; Healy SK
    Mutat Res; 1984; 140(2-3):61-5. PubMed ID: 6379442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rat liver post-microsomal D-T diaphorase: activation of the enzymes by two carcinogens.
    Schor NA; Boh E
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):179-82. PubMed ID: 402684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic activation of 2-acetylaminofluorene.
    Thorgeirsson SS; Wirth PJ; Staiano N; Smith CL
    Adv Exp Med Biol; 1981; 136 Pt B():897-919. PubMed ID: 7046390
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of cytochrome P-450 forms in 2-aminoanthracene and benz[alpha]pyrene mutagenesis.
    Norman RL; Muller-Eberhard U; Johnson EF
    Biochem Biophys Res Commun; 1979 Jul; 89(1):195-201. PubMed ID: 383076
    [No Abstract]   [Full Text] [Related]  

  • 34. Antimutagenic and anti-oxidant activities of the non-steroidal anti-inflammatory drug celecoxib.
    Ajith T; Subin JP; Jacob J; Sanjay PS; Babitha NV
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):888-93. PubMed ID: 16173952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microsome-mediated mutagenicities of the dihydrodiols of 7,12-dimethylbenz[a]anthracene: high mutagenic activity of the 3,4-dihydrodiol.
    Malaveille C; Bartsch H; Tierney B; Grover PL; Sims P
    Biochem Biophys Res Commun; 1978 Aug; 83(4):1468-73. PubMed ID: 100114
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic activation and deactivation of mutagens and carcinogens.
    De Flora S
    Ital J Biochem; 1979; 28(2):81-103. PubMed ID: 399955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic activation of 3-nitroperylene in the Salmonella/S9 assay.
    Anderson JG; McCalla DR; Bryant DW; McCarry BE; Bromke AM
    Mutagenesis; 1987 Jul; 2(4):279-85. PubMed ID: 3325759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activation of the promutagens 2-acetamidofluorene, cyclophosphamide and 7,12-dimethylbenzanthracene by constitutive ferret and rat hepatic S-9 fractions.
    Frederick KA; Babish JG
    Toxicology; 1984 May; 31(1):73-86. PubMed ID: 6427977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does carcinogenic potency correlate with mutagenic potency in the Ames assay?
    Ashby J; Styles JA
    Nature; 1978 Feb; 271(5644):452-5. PubMed ID: 342966
    [No Abstract]   [Full Text] [Related]  

  • 40. Cytosolic potentiation of the rat hepatic microsome mediated mutagenicity of benzidine.
    Smith JN; Ioannides C
    Mutagenesis; 1987 May; 2(3):205-9. PubMed ID: 3325744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.